Safety of absolute coronary flow and microvascular resistance measurements by thermodilution
- PMID: 32091402
- PMCID: PMC9724960
- DOI: 10.4244/EIJ-D-20-00074
Safety of absolute coronary flow and microvascular resistance measurements by thermodilution
Conflict of interest statement
N. Pijls reports institutional grants from Abbott and Hexacath, being a consultant for Abbott, Opsens, and GE, and holding minor equity in Philips, ASML and HeartFlow. The other authors have no conflicts of interest to declare.
Figures
References
-
- Everaars H, de Waard GA, Schumacher SP, Zimmermann FM, Bom MJ, van de Ven PM, Raijmakers PG, Lammertsma AA, Götte MJ, van Rossum AC, Kurata A, Marques KMJ, Pijls NHJ, van Royen N, Knaapen P. Continuous thermodilution to assess absolute flow and microvascular resistance: validation in humans using [15O]H2O positron emission tomography. Eur Heart J. 2019;40:2350–9. doi: 10.1093/eurheartj/ehz245. - DOI - PubMed
-
- Xaplanteris P, Fournier S, Keulards DCJ, Adjedj J, Ciccarelli G, Milkas A, Pellicano M, Veer M, Barbato E, Pijls NHJ, Bruyne BD. Catheter-based measurements of absolute coronary blood flow and microvascular resistance. Circ Cardiovasc Interv. 2018;11:e006194. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources